Cancer Advances, Inc. Announces Publication, “Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model” in Cancer Prevention Research

NEXT STORY
Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO Inhibitors Against SARS-CoV-2 and Variants of Concern, Including Delta, From Texas A&M University
PREV STORY
Dr. Craig Bunnell Joins Advisory Board of Cancer Diagnostic and Precision Oncology Platform Developer 4D Path
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Peregrine Pharmaceuticals Provides Update on Planned Expansion of Bavituximab Clinical Program in Lung, Breast and Other Cancers

-- Phase II Study in NSCLC in Collaboration with AstraZeneca Evaluating Bavituximab Plus Durvalumab ...

author_avatar
NASDAQ Market News

Inovalon Certified by CMS, Receiving Fee-For-Service Medicare Data for All 50 States and the District of Columbia

BOWIE, Md., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading technology company ...

author_avatar
NASDAQ Market News

Parkinson’s Disease Pathogenesis may have a Bacterial Virus Component According to Research Conducted by Human Microbiology Institute

Full study data published in Scientific ReportsNEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News